PRA Health Sciences, Inc.
PRAHDelisted Jul 1, 2021- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001613859
PRA Health Sciences, Inc. was delisted on Jul 1, 2021; its insiders filed their last Form 4 on Jul 1, 2021; 317 institutions reported holding it in 13F filings for Q2 2021, worth $10.1B in total; no superinvestor held it.
13F holders, Q1 2021
Institutional positions in PRA Health Sciences, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 324
- No complete 13F data for Q4 2020
- Shares held
- 62.3M
- No complete 13F data for Q4 2020
- Total value
- $9.55B
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting PRAH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 1 | $1.93M |
| Q2 2021 | 317 | $10.1B |
| Q1 2021 | 324 | $9.55B |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding PRA Health Sciences, Inc..
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 542,426 | $83.2M | 0.02% | – | – |
| Bamco Inc | 551,014 | $84.5M | 0.21% | – | – |
| Morgan Stanley | 557,775 | $85.5M | 0.01% | – | – |
| Norges Bank | 589,263 | $90.4M | 0.02% | – | – |
| Invesco Ltd. | 621,537 | $95.3M | 0.03% | – | – |
| Barclays PLC | 645,564 | $99.0M | 0.10% | – | – |
| Bank of New York Mellon Corp | 684,746 | $105.0M | 0.02% | – | – |
| Pendal Group Limited | 690,070 | $105.8M | 1.04% | – | – |
| Adage Capital Partners GP, L.L.C. | 700,000 | $107.3M | 0.22% | – | – |
| Loomis Sayles & Co L P | 705,343 | $108.2M | 0.14% | – | – |
| Geode Capital Management, LLC | 804,687 | $123.4M | 0.02% | – | – |
| Pentwater Capital Management LP | 929,668 | $142.5M | 1.65% | – | – |
| Citigroup Inc | 1,011,504 | $155.1M | 0.15% | – | – |
| NN Investment Partners Holdings N.V. | 1,076,120 | $165.0M | 0.97% | – | – |
| Alpine Associates Management Inc. | 1,264,820 | $193.9M | 5.26% | – | – |
| Magnetar Financial LLC | 1,402,678 | $215.1M | 2.07% | – | – |
| State Street Corp | 1,459,285 | $223.8M | 0.01% | – | – |
| Wellington Management Group LLP | 2,241,172 | $343.6M | 0.06% | – | – |
| Janus Henderson Group PLC | 2,398,640 | $367.8M | 0.17% | – | – |
| Capital Research Global Investors | 3,425,642 | $525.3M | 0.13% | – | – |
| Price T Rowe Associates Inc | 3,533,621 | $541.8M | 0.05% | – | – |
| Massachusetts Financial Services Co | 5,655,013 | $867.1M | 0.27% | – | – |
| Vanguard Group Inc | 5,969,541 | $915.3M | 0.02% | – | – |
| BlackRock Inc. | 6,627,450 | $1.02B | 0.03% | – | – |